Cti Biopharma reported $275.26M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Applied Genetic Technologies AGTC:US $ 129.01M 38.16M
Baxter International BAX:US $ 40.21B 271.8M
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Cti Biopharma CTIC:US $ 275.26M 42.06M
Cytori Therapeutics CYTX:US $ 29.34M 3.13M
Eli Lilly And LLY:US $ 221.02B 902.49M
Geron GERN:US $ 439.22M 9.96M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Northwest Biotherapeutics NWBO:US 1.12B 135.08M
Novartis NVS:US 200.79B 24.12B
Novartis NOVN:VX 187.04B 20.99B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Sunesis Pharmaceuticals SNSS:US $ 298.55M 121.51M
Teva Pharmaceutical Industries TEVA:US 10.85B 134.37M
YTE INCY:US $ 15.19B 3.31B